Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin

Vaccine

Volumn 26, Issue 38, 2008, Pages 4955-4961

  Ayalew, Sahlu ^a   Confer, Anthony W ^a   Payton, Mark E ^a   Garrels, Kyla D ^a   Shrestha, Binu ^a   Ingram, Kayla R ^a   Montelongo, Marie A ^a   Taylor, Jared D ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Chimeric proteins; Leukotoxin; Mannheimia haemolytica; PlpE; Vaccines

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; LEUKOTOXIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN PLPE; PROTEIN SAC87; PROTEIN SAC89; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BACTERICIDAL ACTIVITY; CATTLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; MANNHEIMIA HAEMOLYTICA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODY FORMATION; ANTITOXINS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BACTERIOLYSIS; BLOOD BACTERICIDAL ACTIVITY; BLOTTING, WESTERN; EPITOPES; EXOTOXINS; FEMALE; LIPOPROTEINS; MANNHEIMIA HAEMOLYTICA; MICE; PASTEURELLACEAE INFECTIONS; RECOMBINANT FUSION PROTEINS;

EID: 50049112419     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.023     Document Type: Article

References (38)

1. Frank G.H. Pasteurellosis of cattle (1989), Academic Press Limited, London
2. Purdy C.W., Raleigh R.H., Collins J.K., Watts J.L., and Straus D.C. Serotyping and enzyme characterization of Pasteurella haemolytica and Pasteurella multocida isolates recovered from pneumonic lungs of stressed feeder calves. Curr Microbiol 34 April (4) (1997) 244-249
3. Welsh R.D. Bacterial and mycoplasma species isolated from pneumonic bovine lungs. Agric Pract 14 (1993) 12-16
4. Al-Ghamdi G.M., Ames T.R., Baker J.C., Walker R., Chase C.C., Frank G.H., et al. Serotyping of Mannheimia (Pasteurella) haemolytica isolates from the upper Midwest United States. J Vet Diagn Invest 12 November (6) (2000) 576-578
5. Perino L.J., and Hunsaker B.D. A review of bovine respiratory disease vaccine field efficacy. Bovine Pract 31 (1997) 59-66
6. Shewen P.E., and Wilkie B.N. Vaccination of calves with leukotoxic culture supernatant from Pasteurella haemolytica. Can J Vet Res 52 January (1) (1988) 30-36
7. Pandher K., Murphy G.L., and Confer A.W. Identification of immunogenic, surface-exposed outer membrane proteins of Pasteurella haemolytica serotype 1. Vet Microbiol 65 March (3) (1999) 215-226 Mar 12
8. Confer A.W., McCraw R.D., Durham J.A., Morton R.J., and Panciera R.J. Serum antibody responses of cattle to iron-regulated outer membrane proteins of Pasteurella haemolytica A1. Vet Immunol Immunopathol July (47) 1-2 (1995) 101-110
9. Mosier D.A., Simons K.R., Confer A.W., Panciera R.J., and Clinkenbeard K.D. Pasteurella haemolytica antigens associated with resistance to pneumonic pasteurellosis. Infect Immun 57 March (3) (1989) 711-716
10. Morton R.J., Panciera R.J., Fulton R.W., Frank G.H., Ewing S.A., Homer J.T., et al. Vaccination of cattle with outer membrane protein-enriched fractions of Pasteurella haemolytica and resistance against experimental challenge exposure. Am J Vet Res 56 July (7) (1995) 875-879
11. Pandher K., Confer A.W., and Murphy G.L. Genetic and immunologic analyses of PlpE, a lipoprotein important in complement-mediated killing of Pasteurella haemolytica serotype 1. Infect Immun 66 December (12) (1998) 5613-5619
12. Ayalew S., Confer A.W., and Blackwood E.R. Characterization of immunodominant and potentially protective epitopes of Mannheimia haemolytica serotype 1 outer membrane lipoprotein PlpE. Infect Immun 72 December (12) (2004) 7265-7274
13. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., Whitworth L.C., and Hammer J.D. Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine. Vaccine 21 June (21-22) (2003) 2821-2829
14. Confer A.W., Ayalew S., Panciera R.J., Montelongo M., and Wray J.H. Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge. Vaccine 24 March (13) (2006) 2248-2255
15. Ayalew S., Blackwood E.R., and Confer A.W. Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2, and 6. Vet Microbiol 114 May (3-4) (2006) 260-268
16. Highlander S.K., Chidambaram M., Engler M.J., and Weinstock G.M. DNA sequence of the Pasteurella haemolytica leukotoxin gene cluster. DNA 8 January-February (1) (1989) 15-28
17. Lo R.Y., Strathdee C.A., and Shewen P.E. Nucleotide sequence of the leukotoxin genes of Pasteurella haemolytica A1. Infect Immun 55 September (9) (1987) 1987-1996
18. Lainson F.A., Murray J., Davies R.C., and Donachie W. Characterization of epitopes involved in the neutralization of Pasteurella haemolytica serotype A1 leukotoxin. Microbiology 142 September (Pt 9) (1996) 2499-2507
19. Gerbig Jr. D.G., Cameron M.R., Struck D.K., and Moore R.N. Characterization of a neutralizing monoclonal antibody to Pasteurella haemolytica leukotoxin. Infect Immun 60 May (5) (1992) 1734-1739
20. Rajeev S., Kania S.A., Nair R.V., McPherson J.T., Moore R.N., and Bemis D.A. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment. Vaccine 19 September (32) (2001) 4842-4850 Sep 14
21. Chae C.H., Gentry M.J., Confer A.W., and Anderson G.A. Resistance to host immune defense mechanisms afforded by capsular material of Pasteurella haemolytica, serotype 1. Vet Microbiol 25 November (2-3) (1990) 241-251
22. Vega M.V., Maheswaran S.K., Leininger J.R., and Ames T.R. Adaptation of a colorimetric microtitration assay for quantifying Pasteurella haemolytica A1 leukotoxin and antileukotoxin. Am J Vet Res 48 November (11) (1987) 1559-1564
23. Liljeqvist S., and Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery stytems and nucleic acid vaccines. J Biotechnol 73 (1999) 1-33
24. Boucher P., Sato H., Sato Y., and Locht C. Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Infect Immun 62 February (2) (1994) 449-456
25. Hertle R., Mrsny R., and Fitzgerald D.J. Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein. Infect Immun 69 November (11) (2001) 6962-6969
26. Nygren PÅ, Ståhl S., and Uhlén M. Engineering proteins to facilitate bioprocessing. Trends Biotechnol 12 (1994) 184-188
27. Moks T., Abrahmsén L., Österlöf B., Josephson S., Östling M., Enfors S.O., et al. Large-scale affinity purification of human insulin-like growth factor I from culture medium of Escherichia coli. Bio/Technology 5 (1987) 379-382
28. Samuelsson E., Wadensten H., Hartmanis M.M.T., and Uhlén M. Facilitated in vitro refolding of human recombinant insulin-like growth factor I using a solubilizing fusion partner. Bio/Technology 9 (1991) 363-366
29. Samuelsson E., Moks T., Nilsson B., and Uhlén M. Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner. J Biochem 33 (1994) 4207-4211
30. Sheoran A.S., Artiushin S., and Timoney J.F. Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin. Vaccine 22 20 (11-12) (2002) 1653-1659
31. Lee S.F., Halperin S.A., Salloum D.F., MacMillan A., and Morris A. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein. Infect Immun 71 4 (2003) 2272-2275
32. Zhang P., Jespersgaard C., Lamberty-Mallory L., Katz J., Huang Y., Hajishengallis G., et al. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Infect Immun 70 12 (2002) 6779-6787
33. Saron M.F., Fayolle C., Sebo P., Ladant D., Ullmann A., and Leclerc C. Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CD8+ T cell epitope from lymphocytic choriomeningitis virus. Proc Natl Acad Sci U S A 94 (1997) 3314-3319
34. Löwenadler B., and Lycke N. Fusion proteins with heterologous T helper epitopes recombinant E. coli heat-stable enterotoxin proteins. Int Rev Immunol 11 (1994) 103-111
35. Hancock G.E., Heers K.M., and Smith J.D. QS-21 synergizes with recombinant interleukin-12 to create a potent adjuvant formulation for the fusion protein of respiratory syncytial virus. Viral Immunol 13 4 (2000) 503-509
36. Taylor P.W. Complement-mediated killing of susceptible gram-negative bacteria: an elusive mechanism. J Exp Clin Immunogenet 9 1 (1992) 48-56
37. Czuprynski C.J., Hamilton H.L., and Noel E.J. Ingestion and killing of Pasteurella haemolytica A1 by bovine neutrophils in vitro. Vet Microbiol 14 May (1) (1987) 61-74
38. Gentry M.J., and Srikumaran S. Neutralizing monoclonal antibodies to Pasteurella haemolytica leukotoxin affinity-purify the toxin from crude culture supernatants. Microb Pathog 10 May (5) (1991) 411-417